Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation

P B Dennis1, S Fumagalli, G Thomas

  • 1Friedrich Miescher Institute, Maulbeerstrasse 66, CH-4058, Basel, Switzerland.

Insights

Cellular growth requires integrating signals, with the target of rapamycin (TOR) pathway mediating environmental cues. Rapamycin studies reveal TOR controls protein synthesis and turnover, highlighting key research questions on its upstream signals and downstream mechanisms.

Area of Science:

  • Cell Biology
  • Molecular Signaling
  • Biochemistry

Background:

  • Cellular growth depends on integrating mitogenic and nutritional signals.
  • The target of rapamycin (TOR) pathway is a key mediator of environmental cues for cell growth.
  • Rapamycin, an immunosuppressant, has been instrumental in dissecting TOR signaling.

Purpose of the Study:

  • To elucidate the role of the target of rapamycin (TOR) pathway in integrating growth signals.
  • To identify signaling components downstream of TOR.
  • To understand the mechanisms of TOR-mediated control over protein synthesis and turnover.

Main Methods:

  • Utilizing the immunosuppressant rapamycin to probe TOR signaling.
  • Investigating downstream effectors of TOR.
  • Analyzing changes in protein synthesis and turnover.

Main Results:

  • Identified downstream signaling components influenced by TOR.
  • Demonstrated that both protein synthesis and protein turnover are regulated by TOR.
  • Established TOR as a central regulator integrating growth-promoting signals.

Conclusions:

  • The TOR pathway is crucial for cellular decision-making regarding growth based on environmental conditions.
  • Further research is needed to identify specific proliferative and anti-proliferative signals upstream of TOR.
  • Understanding TOR signal transduction is key to comprehending cell growth regulation.

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...